These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 9146999)

  • 21. Muscular dystrophies: genes to pathogenesis.
    Dalkilic I; Kunkel LM
    Curr Opin Genet Dev; 2003 Jun; 13(3):231-8. PubMed ID: 12787784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sarcoglycans in muscular dystrophy.
    Hack AA; Groh ME; McNally EM
    Microsc Res Tech; 2000 Feb 1-15; 48(3-4):167-80. PubMed ID: 10679964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intermediate filaments and the function of the dystrophin-protein complex.
    Blake DJ; Martin-Rendon E
    Trends Cardiovasc Med; 2002 Jul; 12(5):224-8. PubMed ID: 12161077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dystrophin and dystrophin-associated proteins. Their evaluation at the neuromuscular pathology laboratory].
    Navarro C
    Rev Neurol; 1999 Jan 16-31; 28(2):154-8. PubMed ID: 10101784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in the molecular genetics of the limb-girdle type of autosomal recessive progressive muscular dystrophy.
    Beckmann JS; Bushby KM
    Curr Opin Neurol; 1996 Oct; 9(5):389-93. PubMed ID: 8894416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dystrophinopathies, congenital muscular dystrophy, limb-girdle dystrophies: updated classification].
    Teijeira-Bautista S; García-García D; Teijeiro-Ferreira A; Fernández-Hojas R; Fernández-Rodríguez JM; Navarro-Fernández-Balbuena C
    Rev Neurol; 1998 Jun; 26(154):1021-6. PubMed ID: 9658487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional profiles from patients with dystrophinopathies and limb girdle muscular dystrophies as determined by qRT-PCR.
    Arning L; Jagiello P; Schara U; Vorgerd M; Dahmen N; Gencikova A; Mortier W; Epplen JT; Gencik M
    J Neurol; 2004 Jan; 251(1):72-8. PubMed ID: 14999492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dystrophies and heart disease.
    Cox GF; Kunkel LM
    Curr Opin Cardiol; 1997 May; 12(3):329-43. PubMed ID: 9243091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular pathophysiology and targeted therapeutics for muscular dystrophy.
    Hoffman EP; Dressman D
    Trends Pharmacol Sci; 2001 Sep; 22(9):465-70. PubMed ID: 11543874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The frequency of patients with dystrophin abnormalities in a limb-girdle patient population.
    Arikawa E; Hoffman EP; Kaido M; Nonaka I; Sugita H; Arahata K
    Neurology; 1991 Sep; 41(9):1491-6. PubMed ID: 1842672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial alpha-sarcoglycan deficiency with retention of the dystrophin-glycoprotein complex in a LGMD2D family.
    Vainzof M; Moreira ES; Canovas M; Anderson LV; Pavanello RC; Passos-Bueno MR; Zatz M
    Muscle Nerve; 2000 Jun; 23(6):984-8. PubMed ID: 10842281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy.
    Herrmann R; Straub V; Blank M; Kutzick C; Franke N; Jacob EN; Lenard HG; Kröger S; Voit T
    Hum Mol Genet; 2000 Sep; 9(15):2335-40. PubMed ID: 11001938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Updates in muscular dystrophies].
    Erazo-Torricelli R
    Rev Neurol; 2004 Nov 1-15; 39(9):860-71. PubMed ID: 15543503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary reduction of alpha7B integrin in laminin alpha2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle.
    Cohn RD; Mayer U; Saher G; Herrmann R; van der Flier A; Sonnenberg A; Sorokin L; Voit T
    J Neurol Sci; 1999 Mar; 163(2):140-52. PubMed ID: 10371075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deficiency of dystrophin-associated proteins in Duchenne muscular dystrophy patients lacking COOH-terminal domains of dystrophin.
    Matsumura K; Tomé FM; Ionasescu V; Ervasti JM; Anderson RD; Romero NB; Simon D; Récan D; Kaplan JC; Fardeau M
    J Clin Invest; 1993 Aug; 92(2):866-71. PubMed ID: 8349821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel gamma-sarcoglycan mutation causing childhood onset, slowly progressive limb girdle muscular dystrophy.
    van der Kooi AJ; de Visser M; van Meegen M; Ginjaar HB; van Essen AJ; Jennekens FG; Jongen PJ; Leschot NJ; Bolhuis PA
    Neuromuscul Disord; 1998 Jun; 8(5):305-8. PubMed ID: 9673983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dystrophin and related proteins.
    Tinsley JM; Blake DJ; Pearce M; Knight AE; Kendrick-Jones J; Davies KE
    Curr Opin Genet Dev; 1993 Jun; 3(3):484-90. PubMed ID: 8353425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dystrophin and muscular dystrophy: past, present, and future.
    O'Brien KF; Kunkel LM
    Mol Genet Metab; 2001; 74(1-2):75-88. PubMed ID: 11592805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Muscular dystrophy due to a deficit of gamma-sarcoglycan. A report of three patients with the Delta-521t mutation].
    Eirís-Puñal J; Pintos-Martínez E; Lasa A; Gallano P; Castro-Gago M
    Rev Neurol; 2002 Mar 1-15; 34(5):486-9. PubMed ID: 12040521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible influences on the expression of X chromosome-linked dystrophin abnormalities by heterozygosity for autosomal recessive Fukuyama congenital muscular dystrophy.
    Beggs AH; Neumann PE; Arahata K; Arikawa E; Nonaka I; Anderson MS; Kunkel LM
    Proc Natl Acad Sci U S A; 1992 Jan; 89(2):623-7. PubMed ID: 1731332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.